ClinVar Miner

Submissions for variant NM_001204.7(BMPR2):c.1605del (p.Arg535fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV003074921 SCV003459937 pathogenic Primary pulmonary hypertension 2022-08-27 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant is also known as c.1604delG. This premature translational stop signal has been observed in individual(s) with pulmonary arterial hypertension (PMID: 29631995). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg535Serfs*29) in the BMPR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BMPR2 are known to be pathogenic (PMID: 16429395).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.